Literature DB >> 15383833

CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors.

Hakim Houchi1, Daniela Babovic, Olivier Pierrefiche, Catherine Ledent, Martine Daoust, Mickaël Naassila.   

Abstract

Cannabinoids and ethanol activate the same reward pathways, and recent advances in the understanding of the neurobiological basis of alcoholism suggest that the CB1 receptor system may play a key role in the reinforcing effects of ethanol and in modulating ethanol intake. In the present study, male CB1 receptors knockout mice generated on a CD1 background displayed decreased ethanol-induced conditioned place preference (CPP) compared to wild-type (CB1(+/+)) mice. Ethanol (0.5, 1.0, 1.5, and 2.0 g/kg) induced significant CPP in CB1(+/+) mice at all doses tested, whereas it induced significant CPP only at the highest dose of ethanol (2.0 g/kg) in CB1(-/-) mice. However, there was no genotypic difference in cocaine (20 mg/kg)-induced CPP. There was also no genotypic difference, neither in cocaine (10-50 mg/kg) nor in D-amphetamine (1.2-5 mg/kg)-induced locomotor effects. In addition, mutant and wild-type mice did not differ in sensitivity to the anxiolytic effects of ethanol (1.5 g/kg) when tested using the elevated plus maze. Interestingly, this decrease in ethanol efficacy to induce CPP in CB1(-/-) mice was correlated with an increase in D2/D3 receptors, as determined by [3H]raclopride binding, whereas there was no difference in D1-like receptors, as determined by [3H]SCH23390 binding, measured in the striatum from drug-naive mice. This increase in D2/D3 binding sites observed in CB1 knockout mice was associated with an altered locomotor response to the D2/D3 agonist quinpirole (low doses 0.02-0.1 mg/kg) but not to an alteration of quinpirole (0.1-1.0 mg/kg)-induced CPP compared to wild-type mice. Altogether, the present results indicate that lifelong deletion of CB1 receptors reduced ethanol-induced CPP and that these reduced rewarding effects of ethanol are correlated to an overexpression of striatal dopamine D2 receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15383833     DOI: 10.1038/sj.npp.1300568

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  68 in total

1.  Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability.

Authors:  Cleo L Crunelle; Elsmarieke van de Giessen; Sybille Schulz; Louk J M J Vanderschuren; Kora de Bruin; Wim van den Brink; Jan Booij
Journal:  Addict Biol       Date:  2011-09-29       Impact factor: 4.280

2.  Selective breeding for high alcohol preference is associated with increased sensitivity to cannabinoid reward within the nucleus accumbens shell.

Authors:  Sheketha R Hauser; Simon N Katner; Robert A Waeiss; William A Truitt; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Pharmacol Biochem Behav       Date:  2020-07-23       Impact factor: 3.533

3.  WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  David A Price; Alex A Martinez; Alexandre Seillier; Wouter Koek; Yolanda Acosta; Elizabeth Fernandez; Randy Strong; Beat Lutz; Giovanni Marsicano; James L Roberts; Andrea Giuffrida
Journal:  Eur J Neurosci       Date:  2009-05-21       Impact factor: 3.386

Review 4.  The endocannabinoid system in brain reward processes.

Authors:  M Solinas; S R Goldberg; D Piomelli
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

5.  Effects of the novel cannabinoid CB1 receptor antagonist PF 514273 on the acquisition and expression of ethanol conditioned place preference.

Authors:  Melanie M Pina; Christopher L Cunningham
Journal:  Alcohol       Date:  2014-05-21       Impact factor: 2.405

6.  BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons.

Authors:  Peng Zhong; Yong Liu; Ying Hu; Tong Wang; Yong-ping Zhao; Qing-song Liu
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

7.  Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions.

Authors:  Panayotis K Thanos; Roberto C Ramalhete; Michael Michaelides; Yianni K Piyis; Gene-Jack Wang; Nora D Volkow
Journal:  Synapse       Date:  2008-09       Impact factor: 2.562

8.  Endocannabinoid signaling in neurotoxicity and neuroprotection.

Authors:  C Pope; R Mechoulam; L Parsons
Journal:  Neurotoxicology       Date:  2009-12-05       Impact factor: 4.294

Review 9.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

10.  Differential Control of Cocaine Self-Administration by GABAergic and Glutamatergic CB1 Cannabinoid Receptors.

Authors:  Elena Martín-García; Lucie Bourgoin; Adeline Cathala; Fernando Kasanetz; Miguel Mondesir; Ana Gutiérrez-Rodriguez; Leire Reguero; Jean-François Fiancette; Pedro Grandes; Umberto Spampinato; Rafael Maldonado; Pier Vincenzo Piazza; Giovanni Marsicano; Véronique Deroche-Gamonet
Journal:  Neuropsychopharmacology       Date:  2015-11-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.